Cerity Partners’s IGM Biosciences IGMS Stock Holding History

Cerity Partners’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,923	Closed	-$13.4K	–	2803
2025 Q2	$13.4K	Sell	11,923 -1,183	-9%	-$1.45K	﹤0.01%	2614
2025 Q1	$15.1K	Buy	13,106 +2,606	+25%	+$4.85K	﹤0.01%	2456
2024 Q4	$174K	Hold	10,500	–	–	﹤0.01%	2260
2024 Q3	$174K	Buy	+10,500	New	+$115K	﹤0.01%	2349
2024 Q2	–	Sell	-10,513	Closed	-$101K	–	2305
2024 Q1	$101K	Buy	+10,513	New	+$122K	﹤0.01%	2205
2021 Q3	–	Sell	-7,000	Closed	-$582K	–	705
2021 Q2	$582K	Buy	7,000 +3,500	+100%	+$259K	0.01%	444
2021 Q1	$268K	Buy	+3,500	New	+$319K	0.01%	578

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cerity Partners's IGMS Position: Q3 2025 in Review

Cerity Partners sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 11,923 shares — an estimated $13.4K sold.

Cerity Partners first reported a position in IGMS in Q1 2021 and held it in 7 quarters. The position peaked at $582K in Q2 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Cerity Partners reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Cerity Partners sold 11,923 IGM Biosciences shares in Q3 2025, an estimated $13.4K.
Cerity Partners first reported a position in IGM Biosciences in Q1 2021 and held it in 7 quarters.
Cerity Partners's IGM Biosciences position peaked at $582K in Q2 2021.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Cerity Partners's 13F filing for Q3 2025, filed 22 Oct 2025.